Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
BMJ Open ; 12(4): e055290, 2022 04 15.
Artigo em Inglês | MEDLINE | ID: mdl-35428630

RESUMO

INTRODUCTION: The objective of this scoping review is to describe the extent and nature of research studies based on linked prescription drug monitoring program (PDMP) data; defined as PDMP data linked to other clinical, administrative or public health data sets. The population is prescribed and dispensed controlled substances. The concept is analysis of linked PDMP data to other clinical, administrative or public health data sets. The context is the USA. METHODS AND ANALYSIS: The scoping review will be conducted with guidance from the latest version of the JBI Manual for Evidence Synthesis, using the framework as outlined by Arksey and O'Malley. Search strategies will be peer-reviewed according to the Peer Review of Electronic Search Strategies (PRESS) guidelines. For transparency and reproducibility, we will adhere to the Preferred Reporting Items for Systematic Reviews and Meta-Analyses extension for Scoping Reviews reporting guidelines in reporting results. Two reviewers will independently screen titles and abstracts, then independently review full text to select papers or studies for inclusion. When consensus cannot be reached with discussion, a third reviewer will resolve the conflicts. From our included studies, we will extract variables describing aspects of population, concept and context (USA). ETHICS AND DISSEMINATION: Ethical approval was not required for this review. This scoping review entails analysis of previously published, peer-reviewed research. We intend to publish findings in a peer-reviewed journal.


Assuntos
Programas de Monitoramento de Prescrição de Medicamentos , Atenção à Saúde , Humanos , Revisão por Pares , Reprodutibilidade dos Testes , Projetos de Pesquisa , Literatura de Revisão como Assunto , Revisões Sistemáticas como Assunto
2.
Front Vet Sci ; 7: 547181, 2020.
Artigo em Inglês | MEDLINE | ID: mdl-33409294

RESUMO

The ever-increasing problem of antibiotic resistance makes routine use of antibiotics in animal production no longer considered as a reasonable and viable practice. The Chicken Farmers of Canada have developed and are implementing an Antimicrobial Use Reduction Strategy, which has the ultimate goal of eliminating the preventive use of medically important antibiotics in broiler chicken and turkey production. However, very little is known about the real overall impact of an antibiotic use reduction strategy in complex ecosystems, such as the bird intestine or the commercial broiler chicken farm. The main objectives of the present study were to compare the abundance of antibiotic resistance-encoding genes, characterize the intestinal microbiota composition, and evaluate the presence of Clostridium perfringens, in six commercial poultry farms adopting short-term antibiotic withdrawal and long-term judicious use strategy. Implementing an antibiotic-free program over a 15-months period did not reduce the abundance of many antibiotic resistance-encoding genes, whereas the judicious use of antibiotics over 6 years was found effective. The short-term antibiotic withdrawal and the long-term judicious use strategy altered the intestinal microbiota composition, with the Ruminococcaceae and Lachnospiraceae families being negatively impacted. These findings are in agreement with the lower production performance and with the increased C. perfringens populations observed for farms phasing out the use of antibiotics. Adopting a conventional rearing program on commercial broiler chicken farms selected for specific antibiotic resistance-encoding genes in many barns. This study highlights the potential impacts of different rearing programs in poultry production and will help guide future policies in order to reduce the use of antibiotics while maintaining production performance.

SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...